Geriatric assessment in older patients with a hematologic malignancy: a systematic review.

ABSTRACT: The aim of this systematic review is to give an update of all currently available evidence on the relevance of a geriatric assessment in the treatment of older patients with hematologic malignancies. A systematic search in MEDLINE and EMBASE was performed to find studies in which a geriatric assessment was used to detect impaired geriatric domains or to address the association between geriatric assessment and survival or clinical outcome measures. The literature search included 4,629 reports, of which 54 publications from 44 studies were included. Seventy-three percent of the studies were published in the last 5 years. The median age of the patients was 73 years (range, 58-86) and 71% had a good World Health Organization (WHO) performance status. The median prevalence of geriatric impairme

SUBMITTER: Scheepers ERM 

PROVIDER: S-EPMC7271571 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature